Effectiveness of antenatal dexamethasone in reducing respiratory distress syndrome and mortality in preterm neonates: a nested case control study

[1]  D. Dewey,et al.  Reducing neonatal mortality and respiratory distress syndrome associated with preterm birth: a scoping review on the impact of antenatal corticosteroids in low- and middle-income countries , 2021, World Journal of Pediatrics.

[2]  R. Barbieri.  Antenatal Dexamethasone Lowers Risk for Neonatal Mortality , 2020 .

[3]  G. Piaggio,et al.  Antenatal dexamethasone for early preterm birth in low-resource countries , 2020, The New England journal of medicine.

[4]  Teshager Worku,et al.  Incidence Density Rate of Neonatal Mortality and Predictors in Sub-Saharan Africa: A Systematic Review and Meta-Analysis , 2020, International journal of pediatrics.

[5]  Emanuel P. Lyimo,et al.  Trends, patterns and cause-specific neonatal mortality in Tanzania: a hospital-based retrospective survey , 2020, International health.

[6]  P. Petrucka,et al.  Incidence of respiratory distress and its predictors among neonates admitted to the neonatal intensive care unit, Black Lion Specialized Hospital, Addis Ababa, Ethiopia , 2020, PloS one.

[7]  T. Habtewold,et al.  Incidence of Respiratory distress and its predictors among neonates admitted at neonatal intensive care unit, Black Lion Specialized Hospital, Addis Ababa, Ethiopia, 2019. , 2019, medRxiv.

[8]  J. Perlman,et al.  Potential causes of early death among admitted newborns in a rural Tanzanian hospital , 2019, PloS one.

[9]  F. Ogbo,et al.  Determinants of trends in neonatal, post-neonatal, infant, child and under-five mortalities in Tanzania from 2004 to 2016 , 2019, BMC Public Health.

[10]  B. Czuba,et al.  A Retrospective Study on the Risk of Respiratory Distress Syndrome in Singleton Pregnancies with Preterm Premature Rupture of Membranes between 24+0 and 36+6 Weeks, Using Regression Analysis for Various Factors , 2018, BioMed research international.

[11]  M. T. Utomo,et al.  The Effect of Antenatal Corticosteroid Therapy to Respiratory Distress Syndrome Event on Preterm Infants in Surabaya , 2018, Biomolecular and Health Science Journal.

[12]  J. Perlman,et al.  A care bundle including antenatal corticosteroids reduces preterm infant mortality in Tanzania a low resource country , 2018, PloS one.

[13]  Julie Brown,et al.  Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.

[14]  J. Stekelenburg,et al.  Antenatal corticosteroid therapy for foetal maturation in women with eclampsia and severe pre-eclampsia in a rural hospital in Western Tanzania , 2016, BMC Pregnancy and Childbirth.

[15]  S. Choukem,et al.  Neonatal respiratory distress in a reference neonatal unit in Cameroon: an analysis of prevalence, predictors, etiologies and outcomes , 2016, The Pan African medical journal.

[16]  Anjali S. Bhandarkar,et al.  A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial , 2015, The Lancet.

[17]  Weiyuan Zhang,et al.  Preterm birth and neonatal mortality in China in 2011 , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[18]  S. Erkaya,et al.  Birth weight for gestational age: A reference study in a tertiary referral hospital in the middle region of Turkey , 2014, Journal of the Chinese Medical Association : JCMA.

[19]  R. T. Lie,et al.  Cause-specific neonatal mortality in a neonatal care unit in Northern Tanzania: a registry based cohort study , 2012, BMC Pediatrics.

[20]  R. Ehrenkranz,et al.  The probability of neonatal respiratory distress syndrome as a function of gestational age and lecithin/sphingomyelin ratio. , 2008, American journal of perinatology.

[21]  M. Malloy.  Impact of Cesarean Section on Neonatal Mortality Rates Among Very Preterm Infants in the United States, 2000–2003 , 2008, Pediatrics.

[22]  M. Miyoshi,et al.  Antenatal treatment with corticosteroids for preterm neonates: impact on the incidence of respiratory distress syndrome and intra-hospital mortality. , 2003, Sao Paulo medical journal = Revista paulista de medicina.

[23]  C. Dani,et al.  Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants , 1999 .

[24]  WHO recommendation on antenatal corticosteroid therapy for women at risk of preterm birth from 24 weeks to 34 weeks of gestation , 2019 .

[25]  R. O. Pérez-Ramírez,et al.  [Neonatal morbidity and mortality associated with low adherence to prenatal corticosteroids]. , 2019, Anales de pediatria.

[26]  W. Fawzi,et al.  Neonatal and Infant Mortality Risk Associated with Preterm and Small for Gestational Age Births in Tanzania: Individual Level Pooled Analysis Using the Intergrowth Standard , 2018, The Journal of pediatrics.

[27]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[28]  C. Dani,et al.  Risk factors for the development of respiratory distress syndrome and transient tachypnoea in newborn infants. Italian Group of Neonatal Pneumology. , 1999, The European respiratory journal.

[29]  J. Nunn.  Respiration in neonates and children , 1987 .